Brief: Anatara Lifesciences Seeks Trading Halt Pending Announcement Regarding Update On Phase II Garp-Ibs Trial
March 6 (Reuters) - Anatara Lifesciences Ltd ANR.AX: SEEKS TRADING HALT PENDING ANNOUNCEMENT REGARDING UPDATE ON PHASE II GARP-IBS TRIAL Further company coverage: ANR.AX ((Reuters.Briefs@thomsonreuters.com))
Recent news on Anatara Lifesciences
See all newsAustralia's Anatara Lifesciences falls on discounted placement
Brief: Anatara Lifesciences Receives Firm Commitments For A$1.2M Placement
Brief: Anatara Lifesciences Seeks Trading Halt
Brief: Anatara Lifesciences Says Hong Kong Patent Granted For GARP Product
Brief: Anatara Lifesciences Seeks Trading Halt Pending Announcement Regarding Update On Phase II Garp-Ibs Trial